An investigation on behalf of investors of Ionis Pharmaceuticals Inc shares over potential securities laws violations by Ionis Pharmaceuticals Inc and certain of its directors and officers was announced. Investors who purchased shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. […]
Nantkwest Inc (NASDAQ:NK) Long Term Investor Alert: Investigation of potential Wrongdoing
An investigation on behalf of current long-term investors in shares of Nantkwest Inc (NASDAQ:NK) concerning potential breaches of fiduciary duties by certain directors and officers of Nantkwest Inc was announced. Investors who are current long term investors in Nantkwest Inc (NASDAQ:NK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call […]
Deadline in Lawsuit for Investors in shares of Banc of California Inc (NYSE:BANC) on March 24, 2017 upcoming
A deadline is coming up on March 24, 2017 in the lawsuit filed for certain investors in NYSE:BANC shares over alleged securities laws violations by Banc of California Inc. Investors who purchased shares of Banc of California Inc (NYSE:BANC) have certain options and there are strict and short deadlines running. Deadline: March 24, 2017. NYSE:BANC […]
Maverick Mattress Biz Wakes Up Tired Industry
When a consumer brand sets an entirely new benchmark, you know they’re on to something big. Very big. This is the case with Nolah, an entrepreneurial, technology and cause-driven mattress company spurring a marketplace movement with a distinctive—and decidedly successful—business model that’s resonating in today’s modern, more empowered marketplace. This “sleeper” turned industry pioneer is […]
Donald Trump Moves Down Forbes List of Billionaires
It was one of the greatest upsets in history when Donald Trump succeeded in winning the top political job in the United States. The New York billionaire took the presidency in a hard-fought battle against Democratic candidate Hilary Clinton. However, Forbes has disclosed that Trump’s financial status hasn’t performed so well. Every year, Forbes publishes […]
NASDAQ:KERX Investor News: Investigation over potential Wrongdoing at Keryx Biopharmaceuticals
An investigation was announced for investors in NASDAQ:KERX shares concerning possible breaches of fiduciary duties by certain officers and directors at Keryx Biopharmaceuticals. Investors who purchased shares of Keryx Biopharmaceuticals (NASDAQ:KERX) and currently hold any of those NASDAQ:KERX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – […]
- « Previous Page
- 1
- …
- 179
- 180
- 181
- 182
- 183
- …
- 12140
- Next Page »